{"abstract": "Teva Pharmaceutical Industries has won the bidding contest for German generic drug maker Ratiopharm, beating out Pfizer and Actavis, three people close to the matter told Reuters.", "web_url": "https://dealbook.nytimes.com/2010/03/18/teva-to-take-over-ratiopharm-report-says/", "snippet": "Teva Pharmaceutical Industries has won the bidding contest for German generic drug maker Ratiopharm, beating out Pfizer and Actavis, three people close to the matter told Reuters.", "lead_paragraph": "8:41 a.m. | Updated Teva Pharmaceutical Industries, the global leader in generic drugs, said Thursday that it had reached a deal to acquire the German generic drug maker Ratiopharm, ending a nine-month battle that had pitted it against at least two other bidders, Natasha Singer reports in The New York Times.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Teva to Acquire Ratiopharm for $5 Billion", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "organizations", "value": "Pfizer Inc", "rank": 1, "major": "N"}, {"name": "organizations", "value": "Ratiopharm", "rank": 2, "major": "N"}, {"name": "glocations", "value": "Germany", "rank": 3, "major": "N"}, {"name": "glocations", "value": "Israel", "rank": 4, "major": "N"}], "pub_date": "2010-03-18T09:15:46+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Dealbook", "person": [{"firstname": "Dealbook", "middlename": null, "lastname": "", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "", "_id": "nyt://article/0df87a59-c9d2-5ad7-b577-521bae7b6352", "word_count": 437, "uri": "nyt://article/0df87a59-c9d2-5ad7-b577-521bae7b6352"}